{"id":1111,"date":"2011-08-04T23:28:34","date_gmt":"2011-08-05T03:28:34","guid":{"rendered":"http:\/\/jamie.workingagenda.com\/blog\/?p=1111"},"modified":"2018-10-22T12:30:41","modified_gmt":"2018-10-22T16:30:41","slug":"host-country-for-firms-selling-cancer-drugs-as-a-monopoly","status":"publish","type":"post","link":"http:\/\/jamie.workingagenda.com\/blog\/2011\/08\/04\/host-country-for-firms-selling-cancer-drugs-as-a-monopoly\/","title":{"rendered":"Host country for firms selling cancer drugs as a monopoly"},"content":{"rendered":"<abbr class=\"unapi-id\" title=\"\"><!-- &nbsp; --><\/abbr>\n<p>Today Paul Miano published this report: Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines, <a href=\"http:\/\/www.keionline.org\/rn2011-1\">KEI Research Note 2011:1<\/a>.<\/p>\n<p>One of the findings of the report:  ownership of cancer drugs sold as a monopoly is concentrated in six countries.   And, 85 percent of patented cancer drugs are owned by firms from the US, the UK and Switzerland.  <!--more--><\/p>\n<p><a href=\"http:\/\/jamie.workingagenda.com\/blog\/wp-content\/uploads\/2011\/08\/monopoly_hosts.png\"><img loading=\"lazy\" src=\"http:\/\/jamie.workingagenda.com\/blog\/wp-content\/uploads\/2011\/08\/monopoly_hosts.png\" alt=\"\" title=\"monopoly_hosts\" width=\"500\" height=\"\" class=\"aligncenter size-full wp-image-1112\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Today Paul Miano published this report: Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines, KEI Research Note 2011:1. One of the findings of the report: ownership of cancer drugs sold as a monopoly is [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[],"_links":{"self":[{"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/posts\/1111"}],"collection":[{"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/comments?post=1111"}],"version-history":[{"count":9,"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/posts\/1111\/revisions"}],"predecessor-version":[{"id":1488,"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/posts\/1111\/revisions\/1488"}],"wp:attachment":[{"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/media?parent=1111"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/categories?post=1111"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/jamie.workingagenda.com\/blog\/wp-json\/wp\/v2\/tags?post=1111"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}